| 國立成功大學 |
2023 |
Long-term use and risk of major adverse cardiac events: Comparing enzalutamide and abiraterone in chemotherapy-na�ve patients with metastatic castration-resistant prostate cancer
|
Chen, H.-K.;Su, P.-J.;Wang, Y.-L.;Chang, K.-C.;Su, Y.-L.;Chang, P.-H.;Kuan, F.-C.;Hsieh, C.-H.;Kuo, Y.-C.;Sheng, T.-W.;Chang, Chang C.-F.;Yu, S.-M.;Huang, W.-K.;Lin, Y.-C.;Tsan, D.-L.;Yu, K.-J.;Lin, P.-H.;Chen, H.-Y.;Chang, Y.-H.;Pang, S.-T.;Chuang, Chuang C.-K.;Lai, E.C.-C. |
| 臺大學術典藏 |
2021-10-14T02:45:34Z |
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer
|
Cha T.-L.; Wu T.T.-L.; Vogelzang N.J.; CHAO-YUAN HUANG; Huang S.-P.; Lin C.-C.; Ou Y.-C.; Pang S.-T.; Shen D.H.-Y.; Wu W.-J.; Chang W.Y.-H. |
| 臺大學術典藏 |
2021-10-14T02:45:20Z |
Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing
|
LIN P.-H.; CHAO-YUAN HUANG; YU K.-J.; KAN H.-C.; LIU C.-Y.; CHUANG C.-K.; LU Y.-C.; CHANG Y.-H.; SHAO I.H.; PANG S.-T. |
| 臺大學術典藏 |
2021-02-02T00:46:12Z |
The efficacy of abiraterone acetate in treating Taiwanese chemo-refractory metastatic castration-resistant prostate cancer patients
|
Wu T.;Wu H.C.;Ou Y.C.;Pang S.-T.;Yeong-Shiau Pu;Chang Y.-H.; Wu T.; Wu H.C.; Ou Y.C.; Pang S.-T.; YEONG-SHIAU PU; Chang Y.-H. |
| 臺大學術典藏 |
2021-01-28T08:27:29Z |
Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing
|
LIN P.-H.; HUANG C.-Y.; YU K.-J.; KAN H.-C.; LIU C.-Y.; CHUANG C.-K.; YU-CHUAN LU; CHANG Y.-H.; SHAO I.H.; PANG S.-T. |
| 臺大學術典藏 |
2020-11-19T03:19:12Z |
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
|
Hsieh S.-Y.; Chang A.Y.; Teh B.T.; Rozen S.G.; PO-HUANG LEE; Huang H.-Y.; Yu M.-C.; Pang S.-T.; Tan P.; Ng C.C.Y.; Lim J.Q.; Ng A.W.T.; Poon S.L.; Huang M.N.; Thangaraju S.; Suzuki Y.; Boot A.; Yu W. |
| 臺大學術典藏 |
2020-05-25T07:35:14Z |
Optimal usage of radium-223 in metastatic castration-resistant prostate cancer
|
Cha T.-L; Wu T.T.-L; Vogelzang N.J; Huang C.-Y; Huang S.-P; Chia-Chi Lin; Ou Y.-C; Pang S.-T; Shen D.H.-Y; Wu W.-J; Chang W.Y.-H. |
| 臺大學術典藏 |
2020-02-10T08:59:57Z |
Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer
|
KUAN-CHEN CHENG;Lin S.-K.;Pang S.-T.;Cheng K.-C.;Chang Y.-H.;Hsu R.-J.;Lin P.-H.;Liu J.-M.; Liu J.-M.; Lin P.-H.; Hsu R.-J.; Chang Y.-H.; Cheng K.-C.; Pang S.-T.; Lin S.-K.; KUAN-CHEN CHENG |
| 臺大學術典藏 |
2019-07-11T03:52:39Z |
Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer
|
Lin S.-K.;Pang S.-T.;Cheng K.-C.;Chang Y.-H.;Hsu R.-J.;Lin P.-H.;Liu J.-M.; Liu J.-M.; Lin P.-H.; Hsu R.-J.; Chang Y.-H.; Cheng K.-C.; Pang S.-T.; Lin S.-K. |
| 國立臺北護理健康大學 |
2018 |
Effects of individual and partner factors on anxiety and depression in Taiwanese prostate cancer patients: A longitudinal study
|
Chien, C.H.; Chuang, C.K.; Liu, K.L.; Wu, C.T.; Pang, S.T.; Tsay, P.K.; Chang, Y.H.; Huang, X.Y.; Liu, H.E. |
| 臺大學術典藏 |
2016 |
Complementary traditional Chinese medicine therapy improves survival in patients with metastatic prostate cancer
|
KUAN-CHEN CHENG;Lin S.-K.;Pang S.-T.;Cheng K.-C.;Chang Y.-H.;Hsu R.-J.;Lin P.-H.;Liu J.-M.; Liu J.-M.; Lin P.-H.; Hsu R.-J.; Chang Y.-H.; Cheng K.-C.; Pang S.-T.; Lin S.-K.; KUAN-CHEN CHENG |
